Post-Market Clinical Follow-up Study to Evaluate the Safety and Performance of Remplir™ Collagen Membrane in Peripheral Nerve Surgery

Remplir is a collagen membrane — a thin, biocompatible sheet made from a natural protein — that is used during peripheral nerve surgery to wrap around and protect repaired nerves. It is designed to reduce scar tissue formation around the nerve after surgery, which can otherwise limit recovery. This post-market study is collecting real-world data on how Remplir performs across a wide range of peripheral nerve procedures and patient types. Both past patients (retrospective) who have already had Remplir used in their surgery and new patients (prospective) who will have it used will be included. Data on nerve function recovery, surgical outcomes, and any complications will be collected and analysed. You may be eligible if you have undergone (or are about to undergo) a peripheral nerve surgical procedure in which Remplir was or will be used. There are no specific age restrictions. People who participated in the original CG-006 clinical trial for Remplir, or those who have specifically stated they do not want their data used for research, are not eligible. This study will help build the evidence base for this medical device and guide its use in future nerve surgery.